Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats.
暂无分享,去创建一个
H. Lippton | H. Champion | P. Kadowitz | Hunter C Champion | A. Hyman | A. Tower | Albert L Hyman | Qingzhong Hao | Allen Tower | Philip J Kadowitz | Bulent Gumusel | Howard Lippton | B. Gumusel | Q. Hao
[1] S. Moncada,et al. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[2] I L Buxton,et al. NG-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. , 1993, Circulation research.
[3] D. Rodman,et al. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. , 1991, The American journal of physiology.
[4] C. Pang,et al. Effects of calcitonin gene‐related peptide receptor antagonists on renal actions of adrenomedullin , 1995, British journal of pharmacology.
[5] J. López-Belmonte,et al. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation , 1989, British journal of pharmacology.
[6] B. Walker,et al. Role of nitric oxide in vasopressinergic pulmonary vasodilatation. , 1992, American Journal of Physiology.
[7] M. Heymann,et al. In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue. , 1991, Journal of applied physiology.
[8] P. Rock,et al. N omega-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs. , 1992, The American journal of physiology.
[9] T. McMahon,et al. N omega-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. , 1991, Journal of applied physiology.
[10] S. Moncada,et al. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. , 1990, Acta physiologica Scandinavica.
[11] T. Evans,et al. Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling. , 1993, Journal of applied physiology.
[12] G. Burnstock,et al. Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat , 1995, British journal of pharmacology.
[13] A. Hyman. Effects of large increases in pulmonary blood flow on pulmonary venous pressure. , 1969, Journal of applied physiology.
[14] S. Gardiner,et al. Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin‐1 in conscious rats: effects of NG‐nitro‐l‐arginine methyl ester , 1990, British journal of pharmacology.
[15] R. Ekman,et al. CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension. , 1992, The American journal of physiology.
[16] C. Dawson,et al. 4. Pulmonary Vascular Resistance (P:Q Relations) , 1990 .
[17] O. Griffith,et al. L-arginine availability determines the duration of acetylcholine-induced systemic vasodilation in vivo. , 1989, Biochemical and biophysical research communications.
[18] S. Abman,et al. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. , 1990, The American journal of physiology.
[19] T. Evans,et al. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. , 1991, The American review of respiratory disease.
[20] A. Cadieux,et al. Rat adrenomedullin induces a selective arterial vasodilation via CGRP1 receptors in the double-perfused mesenteric bed of the rat. , 1995, Canadian journal of physiology and pharmacology.
[21] J. Wallwork,et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. , 1991, The New England journal of medicine.
[22] C. Emery,et al. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. , 1993, The Journal of physiology.
[23] S. Archer,et al. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. , 1989, Biochemical and biophysical research communications.
[24] L. Ignarro,et al. Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. , 1987, Circulation research.
[25] T. Burke-Wolin,et al. NO and H2O2 mechanisms of guanylate cyclase activation in oxygen-dependent responses of rat pulmonary circulation. , 1995, The American journal of physiology.
[26] S. Soifer,et al. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. , 1992, The American journal of physiology.
[27] K. Margulies,et al. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. , 1991, The American journal of physiology.
[28] C. Emery,et al. Enhanced reactivity to bradykinin, angiotensin I and the effect of captopril in the pulmonary vasculature of chronically hypoxic rats. , 1990, The European respiratory journal.
[29] M. Heymann,et al. N omega-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. , 1991, The American journal of physiology.
[30] S. Archer,et al. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. , 1994, Journal of applied physiology.
[31] T. Evans,et al. Inhibitory role of endothelium‐derived relaxing factor in rat and human pulmonary arteries , 1990, British journal of pharmacology.
[32] A. Kaye,et al. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. , 1996, The American journal of physiology.
[33] M. Oka,et al. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs. , 1993, The American journal of physiology.
[34] A. Bouhuys. The Pulmonary Circulation and Interstitial Space , 1970, The Yale Journal of Biology and Medicine.
[35] S. Archer,et al. NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. , 1992, Biochemical and biophysical research communications.
[36] J. Stamler,et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.
[37] P. S. Wilson,et al. Effect of nitric oxide and cyclooxygenase products on vascular resistance in dog and rat lungs. , 1993, Journal of applied physiology.
[38] K. Abromeit. Music Received , 2023, Notes.
[39] H. Lippton,et al. Interaction of human adrenomedullin 13–52 with calcitonin gene‐related peptide receptors in the microvasculature of the rat and hamster , 1995, British journal of pharmacology.
[40] P. Kadowitz,et al. Pulmonary vasoconstrictor responses to graded decreases in precapillary blood PO2 in intact-chest cat. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.
[41] A. Kaye,et al. Influence of N omega-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation. , 1994, European journal of pharmacology.
[42] M. Peach,et al. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. , 1988, The Journal of clinical investigation.